跳到主要导航 跳到搜索 跳到主要内容

Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection

  • Zhi-Feng Zhang
  • , Juan Chen
  • , Xin Han
  • , Ya Zhang
  • , Hua-Bao Liao
  • , Rui-Xue Lei
  • , Yang Zhuang
  • , Ze-Fen Wang
  • , Zhiqiang Li
  • , Jin-Cao Chen
  • , Wei-Jing Liao
  • , Hai-Bing Zhou
  • , Fang Liu
  • , Qi Wan*
  • *此作品的通讯作者
  • Univ Toronto

科研成果: 期刊稿件 › 论文 › 同行评审

48 引用 (Scopus)

摘要

["BACKGROUND AND PURPOSE We and others have shown that inhibiting phosphatase and tensin homolog deleted on chromosome 10 (PTEN) or activating ERK1/ 2 confer neuroprotection. As bisperoxovanadium compounds are well-established inhibitors of PTEN, we designed bisperoxovandium (pyridin-2-squaramide) [ bpV(pis)] and determined whether and how bpV(pis) exerts a neuroprotective effect in cerebral ischaemia-reperfusion injury.","EXPERIMENTAL APPROACH Malachite green-based phosphatase assay was used to measure PTEN activity. A western blot assay was used to measure the phosphorylation level of Akt and ERK1/ 2 (p-Akt and p-ERK1/ 2). Oxygen-glucose deprivation (OGD) was used to injure cultured cortical neurons. Cell death and viability were assessed by LDH and MTT assays. To verify the effects of bpV(pis) in vivo, Sprague-Dawley rats were subjected to middle cerebral artery occlusion, and brain infarct volume was measured and neurological function tests performed.","KEY RESULTS bpV(pis) inhibited PTEN activity and increased p-Akt in SH-SY5Y cells but not in PTEN-deleted U251 cells. bpV(pis) also elevated p-ERK1/ 2 in both SH-SY5Y and U251 cells. These data indicate that bpV(pis) enhances Akt activation through PTEN inhibition but increases ERK1/ 2 activation independently of PTEN signalling. bpV(pis) prevented OGD-induced neuronal death in vitro and reduced brain infarct volume and promoted functional recovery in stroke animals. This neuroprotective effect of bpV(pis) was blocked by inhibiting Akt and/ or ERK1/ 2.","CONCLUSIONS AND IMPLICATIONS bpV(pis) confers neuroprotection in OGD-induced injury in vitro and in cerebral ischaemia in vivo by suppressing PTEN and activating ERK1/ 2. Thus, bpV(pis) is a bi-target neuroprotectant that may be developed as a drug candidate for stroke treatment."]
源语言英语
页(从-至)641-656
页数16
期刊British Journal of Pharmacology
卷174
期8
DOI
出版状态已出版 - 4月 2017

基金资助

This work was supported by China Key Project of Basic Research ('973' Project; 2014CB541606), Natural Science Foundation of China (NSFC; 81470599) and Fund of Collaborative Innovation Center for Brain Science to Q.W.

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

关键词

  • Animals
  • Brain Ischemia
  • Cell Death
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors
  • Glucose
  • Humans
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Neurons
  • Neuroprotective Agents
  • Oxygen
  • PTEN Phosphohydrolase
  • Rats
  • Rats, Sprague-Dawley
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • Vanadium Compounds
  • bisperoxovanadium
  • lactate dehydrogenase
  • mitogen activated protein kinase 1
  • neuroprotective agent
  • phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase
  • unclassified drug
  • enzyme inhibitor
  • glucose
  • mitogen activated protein kinase 3
  • oxygen
  • PTEN protein, human
  • vanadium derivative
  • animal experiment
  • animal model
  • Article
  • brain cell
  • brain infarction size
  • brain ischemia
  • cell death
  • cell viability
  • drug efficacy
  • drug mechanism
  • drug response
  • drug targeting
  • enzyme activity
  • enzyme inhibition
  • human
  • human cell
  • IC50
  • male
  • middle cerebral artery occlusion
  • neuroprotection
  • nonhuman
  • protein phosphorylation
  • rat
  • treatment outcome
  • animal
  • chemistry
  • disease model
  • dose response
  • drug effects
  • metabolism
  • nerve cell
  • pathology
  • Sprague Dawley rat
  • structure activity relation
  • synthesis
  • tumor cell culture

收录

  • Scopus
  • SCIE

学术指纹

探究 'Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection' 的科研主题。它们共同构成独一无二的学术指纹。

引用此